Despite a lack of evidence to support drain insertion in thyroid surgery, drain placement, to prevent rapidly expanding haematoma which occurs in around 1% of cases, remains common 1,2,3. Throughout surgery there has been a drive towards reducing postoperative length of hospital admission. For day-case thyroidectomy to become a widely adopted clinical reality, the use of drains requires abandonment, but beyond this, the cause for surgeons' reticence to practise drain-free surgery, namely haematoma risk, needs to be addressed. This paper describes a study conducted to examine the efficacy of ARTISS™, a commercially available thrombin-dilute fibrin sealant, in thyroid surgery to permit safe transition to drain-free surgery.
This article is protected by copyright. All rights reserved.
http://ift.tt/2kVqXZ4
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου